Effects of functional toll-like receptor-4 mutations on the immune response to human and experimental sepsis

Immunology

Volumn 109, Issue 3, 2003, Pages 426-431

  Feterowski, Carolin ^a   Emmanuilidis, Klaus ^a   Miethke, Thomas ^a   Gerauer, Klaus ^a   Rump, Martina ^a   Ulm, Kurt ^b   Holzmann, Bernhard ^a   Weighardt, Heike ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MUTANT PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ABDOMINAL SURGERY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PERITONITIS; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; TREATMENT OUTCOME; WILD TYPE;

AGED; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MIDDLE AGED; MUTATION; PERITONITIS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECEPTORS, CELL SURFACE; SEPSIS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 0038466078     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01674.x     Document Type: Article

References (19)

1. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-80.
2. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20:197-216.
3. Beutler B, Poltorak A. Sepsis and evolution of the innate immune response. Crit Care Med 2001; 29:S2-S7.
4. Smirnova I, Poltorak A, Chan EKL, McBride C, Beutler B, Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4). Genome Biol 2000; 1:research002.1-002.10.
5. Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25:187-91.
6. Lorenz E, Mira J-P. Cornish KL, Arbour NC. Schwartz DA. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68:6398-401.
7. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-55.
8. Zantl N, Uebe A, Neumann B et al. Essential role of γ-interferon in survival of colon ascendens stem peritonitis, a novel murine model of abdominal sepsis. Infect Immun 1998; 66:2300-9.
9. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 112:235-43.
10. Dinarello CA. Cytokines as mediators in the pathogenesis of septic shock. Curr Top Microbiol Immunol 1996; 216:133-65.
11. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162:1028-32.
12. Hoshino K, Takeuchi O, Kawai T et al. Toll-like receptor 4 (TLR4) deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the lps gene product. J Immunol 1999; 162:3749-52.
13. Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443-51.
14. Maier S, Emmanuilidis K, Entleutner M, Zantl N, Werner M, Pfeffer K, Heidecke CD. Massive chemokine transcription in acute renal failure due to polymicrobial sepsis. Shock 2001; 14:187-92.
15. Weighardt H, Kaiser-Moore S, Vabulas RM, Kirschning C, Wagner H, Holzmann B. Cutting edge: Myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J Immunol 2002; 169:2823-7.
16. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Calvano SE, Lowry SF. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002; 186:1522-5.
17. Read RC, Pullin J, Gregory S et al. A functional polymorphism of Toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 2002; 184:640-2.
18. Reinhart K, Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 2001; 29:121-5.
19. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11:115-22.